NEWS
Bachem Group with new production unit for cytotoxic substances
29. Mar 2006
The Bachem Group announced today that, at the end of 2005, its subsidiary Sochinaz SA completed the construction of a new production unit at its site in Vionnaz, Switzerland, for the manufacture of cytotoxic and cytostatic substances. These substances are used as active ingredients for cancer therapy and have to be manufactured according to the strictest safety requirements for both staff and the environment. The investments for the plant, which is licensed for production according to Good Manufacturing Practice (cGMP) principles, amounted to CHF 4 million.